DavidTsaiTingMD

Assistant Professor, Medicine-Massachusetts General Hospital, Harvard Medical School

Dr. Ting is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. David Ting is an oncologist in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from Harvard Medical School and has been in practice 13 years.

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2007 - 2010
Massachusetts General HospitalResidency, Internal Medicine, 2004 - 2007
Harvard Medical SchoolClass of 2004

PubMed

2 citations
Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer.
Eunae You, Patrick Danaher, Chenyue Lu, Siyu Sun, Luli Zou
Cell. 2024-12-12
Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms.
Siyu Sun, Eunae You, Jungeui Hong, David Hoyos, Isabella Del Priore
Immunity. 2024-12-10
Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic Cancer.
Slavica Dimitrieva, Jon M Harrison, Jonathan Chang, Michelle Piquet, Mari Mino-Kenudson
Cancer Research Communications. 2024-12-01

Journal Articles

The Histologic Diagnosis of IgG4‐Related Disease on Small Biopsies: Challenges and Pitfalls
Vikram Deshpande, David T Ting, Histopathology

Study Reveals How Cancer Immunotherapy Leads to Deadly Form of Heart Inflammation in Some PatientsNovember 6th, 2024
Oncology Round-up: Distinguishing Prostate Cancer Lesions, Reverse Transcriptase Inhibitors; And MoreApril 15th, 2022
Reverse Transcriptase Inhibitors Used in HIV Therapies Stop Disease Progression in Metastatic Colorectal CancerApril 12th, 2022
Join now to see all